An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity
Keywords: alpha adrenergic receptors; anthracyclines; cardioprotection; catecholamines; heart failure; α1-AR; alpha-1 adrenergic receptor; AKO; alpha-1A adrenergic receptor knockout; ATP; adenosine triphosphate; BP; blood pressure; DOX; doxorubicin; EC50; half-max